Tonix Pharmaceuticals Holding (TNXP) Work In Process (2023 - 2025)

Tonix Pharmaceuticals Holding's Work In Process history runs 3 years deep, the most recent figure standing at $1.4 million for Q4 2025.

• On a quarterly basis, Work In Process rose 543.19% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a 543.19% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 543.19% from the prior year.
• Work In Process retreated to $1.4 million in Q4 2025 per TNXP's latest filing, from $1.5 million in the prior quarter.
• Across five years, Work In Process topped out at $2.5 million in Q4 2023 and bottomed at $213000.0 in Q4 2024.
• The 3-year median for Work In Process is $1.4 million (2025), against an average of $1.4 million.
• Across the five-year window, Work In Process sank 91.61% in 2024 and jumped 543.19% in 2025, its largest moves.
• Year by year, Work In Process stood at $2.5 million in 2023, then sank by 91.61% to $213000.0 in 2024, then soared by 543.19% to $1.4 million in 2025.
• Per Business Quant, the three latest TNXP Work In Process figures stand at $1.4 million (Q4 2025), $1.5 million (Q3 2025), and $1.3 million (Q2 2025).